TENA SmartCare Change Indicator™对养老院老年住民尿失禁护理效率与皮肤健康影响的上市后整群随机对照试验
该整群随机对照试验(NCT05247047)纳入无法一致表达如厕需求的养老院尿失禁老年住民及其护理员,比较基于TENA SmartCare Change Indicator的失禁护理与常规护理为期8周的效果,共同主要终点为护理效率的优效性与皮肤健康维持的非劣效性。
要点
- 该试验比较TENA SmartCare Change Indicator与常规失禁护理,为期8周。
- 共同主要终点为护理效率优效性与皮肤健康维持非劣效性。
- 次要结局包括住民生活质量、睡眠质量、反应性行为及护理员工作投入等。
核心结论
- 若被证明有效,该技术方案有潜力改善老年住民的护理并改善护理员的工作生活,但本文为试验方案,尚未报告效果数据。
研究设计与样本
- 上市后整群随机对照试验(NCT05247047),纳入无法一致表达如厕需求的养老院尿失禁老年住民及其护理员,比较技术辅助失禁护理与常规护理,为期8周。
主要发现
- 本文为试验方案,未报告试验结果数据。
关键数值与推荐
- 共同主要终点为护理效率的优效性与皮肤健康维持的非劣效性。
- 次要结局包括住民生活质量、睡眠质量、反应性行为、尿垫使用变化及尿垫外漏尿事件。
- 次要结局还包括护理员工作投入、工作满意度及仓促完成任务的变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinary continence care for residents of nursing homes who are unable to communicate their toileting needs usually involves care aides manually checking continence products (pads) to determine the level of urine saturation prior to changing. The TENA SmartCare Change Indicator is a medical device which estimates urine saturation and notifies caregivers of the optimal time for pad changes. This study will seek to examine the effect of the TENA SmartCare Change Indicator on urinary continence care efficiency and skin health, in comparison to usual care. METHODS: This cluster randomized controlled trial (NCT05247047) involving older nursing home residents with urinary incontinence unable to consistently indicate their toileting needs, and their care aides, will compare technology-based and usual continence care over a period of 8 weeks. Co-primary endpoints of superiority in continence care efficiency and non-inferiority in the maintenance of skin health will be assessed. Secondary outcomes will examine the resident quality of life, sleep quality, responsive behaviours, changes in pad use and leakage episodes outside the pad. Change in care aide work engagement, job satisfaction and rushed tasks will be assessed. Benefits and challenges with the use of the device for continence care will be identified from the perspectives of the care staff. DISCUSSION: Urinary continence assessment and care in nursing homes is reported as suboptimal and threatening to dignity. Data on the utility and effect of technological solutions for improving urinary continence care are few and conflicting. If shown effective, this technological solution has the potential to improve the care for older residents and improve the working lives of caregiving staff who look after this most vulnerable section of the population. TRIAL REGISTRATION: ClinicalTrials.gov NCT05247047. Registration date is Feb 18, 2022.
引用
- Omotunde M, Agholme F, Böhling A, et al. A post-market cluster randomized controlled trial of the effect of the TENA SmartCare Change Indicator™ on urinary continence care efficiency and skin health in older nursing home residents. Trials. 2023. PMID: 36737838. doi:10.1186/s13063-022-07031-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。